Tablet
RANEXA PROLONGED-RELEASE TABLETS 375MG
Summary
RANEXA PROLONGED-RELEASE TABLETS 375MG — Tablet containing ranolazine. Hong Kong Registration No. HK-63607. Certificate Holder: A. MENARINI HONG KONG LIMITED. Date of Registration: 30 Apr, 2015.
Product NameRANEXA PROLONGED-RELEASE TABLETS 375MG
Registration No.HK-63607
Certificate HolderA. MENARINI HONG KONG LIMITED
Holder Address20/F, CROCODILE CENTER, NO. 79, HOI YUEN ROAD, KWUN TONG, KOWLOON
Ingredientsranolazine
Dosage FormTablet
Legal ClassificationPart 1, Schedule 1 & Schedule 3 Poison
Sale RequirementPrescription only Medicines
Date of Registration30 Apr, 2015
ATC codesC01EB18
ATC Classification
ATC level 1
C Cardiovascular System
All ATC groupsC01
本頁為藥物資料查詢工具，並非藥物廣告、推廣或醫療建議。所有資料取自香港特別行政區衞生署藥物辦公室之公開資料，僅供參考；一切以藥物辦公室官方公布為準。 本頁不提供任何療效、適應症或治療用途之陳述。用藥前請諮詢醫生或註冊藥劑師。 本網站遵守香港法例第 231 章《不良廣告（醫藥）條例》之規管。